# OnCo record capecitabine-temozolomide (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/capecitabine-temozolomide/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "capecitabine-temozolomide" ;
  schema:name "Capecitabine + temozolomide (CAPTEM)"@en ;
  schema:description "CAPTEM (capecitabine plus temozolomide) is an all-oral chemotherapy pair that shrinks pancreatic neuroendocrine tumours in about a third of patients."@en ;
  schema:url <https://onco.cc/drugs/capecitabine-temozolomide/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01824875> ;
  onco:status "established" ;
  onco:modality "Oral cytotoxic regimen" ;
  onco:cancers <https://onco.cc/cancers/neuroendocrine/>, <https://onco.cc/cancers/pancreatic-net/>, <https://onco.cc/cancers/grade-3-net/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/> ;
  onco:companies <https://onco.cc/companies/ecog-acrin/> ;
  onco:terms <https://onco.cc/terms/mgmt/> ;
  onco:trials <https://onco.cc/trials/nct04919226/> .